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Abstract
The retinal pigment epithelium (RPE), a monolayer located between the photoreceptors and the choroid, is constantly damaged by oxidative
stress, particularly because of reactive oxygen species (ROS). As the RPE, because of its physiological functions, is essential for the survival of
the retina, any sustained damage may consequently lead to loss of vision. Exosomes are small membranous vesicles released into the extracel-
lular medium by numerous cell types, including RPE cells. Their cargo includes genetic material and proteins, making these vesicles essential
for cell-to-cell communication. Exosomes may fuse with neighbouring cells influencing their fate. It has been observed that RPE cells release
higher amounts of exosomes when they are under oxidative stress. Exosomes derived from cultured RPE cells were isolated by ultracentrifuga-
tion and quantified by flow cytometry. VEGF receptors (VEGFR) were analysed by both flow cytometry and Western blot. RT-PCR and qPCR
were conducted to assess mRNA content of VEGFRs in exosomes. Neovascularization assays were performed after applying RPE exosomes into
endothelial cell cultures. Our results showed that stressed RPE cells released a higher amount of exosomes than controls, with a higher expres-
sion of VEGFR in the membrane, and enclosed an extra cargo of VEGFR mRNA. Angiogenesis assays confirmed that endothelial cells increased
their tube formation capacity when exposed to stressed RPE exosomes.
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Introduction
Exosomes are small vesicles, between 50 and 150 nm in diameter
[1], released by a number of different cell types [2–5]. Invaginations
in the late endosome limiting membrane produce a multivesicular
body (MVB) full of intraluminal vesicles [6]. Once the MVB is formed,
it can fuse with the cell membrane releasing its cargo to the extracel-
lular medium, which might subsequently interact with neighbouring
cells [7]. As such, exosomes can be found in many corporal fluids,
including blood, saliva, breast milk and even aqueous humour [8–
11]. Exosome cargo is comprised of genetic material and proteins,
making these vesicles essential in cell communication [12].
The retinal pigment epithelium (RPE), a single cell layer that sepa-
rates blood vessels from photoreceptors, accomplishes a pivotal role
in retinal homoeostasis [13–15]. As a result of its anatomical location
and function, the RPE is continuously exposed to potential cell dam-
age from oxidative stress, specifically because of reactive oxygen
species (ROS) [16].
Neovascularization, or the formation of new blood vessels, is one
of the most common hallmarks of blinding diseases, such as the pro-
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liferative forms of age-related macular degeneration (AMD) and dia-
betic retinopathy (DR) [17, 18]. Moreover, oxidative stress induces
the formation of angiogenic factors, of which VEGF is most com-
monly known [19]. Although VEGF has normal physiological func-
tions in the retina [20, 21], elevated levels of secretion contributes to
the development of new blood vessels, as seen in wet AMD and pro-
liferative DR [22]. VEGF-A, the main isoform of the protein, acts
through VEGFR-1 and VEGFR-2, VEGF receptors present in endothe-
lial cells of blood vessels [23]. Moreover, it was recently suggested
that ROS induce VEGF secretion, thus resulting in enhanced neovas-
cularization [24, 25]. VEGF can be released by different retinal cells,
such as RPE cells [26, 27], M€uller cells [28] and choroid endothelial
cells [29]. VEGFR-1 and -2 can be expressed in neural, glial and vas-
cular cells [18]. In fact, VEGFR-2 levels were noted to be increased in
vascular elements in patients suffering DR [30]. Though it is well
established that neovascularization is brought upon by high VEGF
levels and increased VEGFR-1 and VEGFR-2 expression, the mecha-
nisms of such overproduction in AMD or DR are still unidentified.
Moreover, oxidative stress can be promoted through ethanol treat-
ment [31], which has been demonstrated to enhance neovasculariza-
tion in different tissues [32], including the choroid [33, 34].
It has been recently shown that certain exosomes are able to
either promote or inhibit neovascularization [35, 36], but the mecha-
nisms clarifying those events are poorly understood. The aim of the
present study was to observe exosome secretion and alterations in
exosomal cargo from stressed RPE cells and elucidate their potential
role in angiogenesis. It has been suggested that damaged RPE exo-
somes secreted to the extracellular medium may carry a different
cargo than healthy RPE exosomes. Levels of angiogenic factors, such
as VEGF receptors, might be altered, which would thereby influence
neighbouring endothelial cells. We have hereby demonstrated that the
protein and mRNA exosomal cargo for VEGFR-1 and VEGFR-2 are
increased when RPE cells are under stress, and that these exosomes
may interact with endothelial cells influencing their angiogenic
capability.
Materials and methods
Cell culture
Arising retinal pigment epithelium (ARPE-19) human cell line was
obtained from American Type Culture Collection (ATCC, Barcelona,
Spain). ARPE-19 cells were cultured as previously described [31, 37].
Cells were used from 18 to 20 passages and cultured to 80–90% con-
fluence in p100 culture well plates at a seeding density of 1 9 106
cells/cm2. The use of sub-confluent cell cultures might be a limitation
for the direct applicability of the results to the physiological situation,
though these sub-confluent conditions are largely accepted in oxidative
stress studies [25, 31, 37]. Cells were treated for 24 hrs at different
ethanol concentrations: 40 and 80 mM (absolute ethanol; Biosolve,
Valkenswaard, The Netherlands). Subsequently, cells and supernatant
were collected and preserved for future experiments.
Human umbilical vein endothelial cells (HUVEC) were isolated as
described previously [38]. Briefly, umbilical veins were perfused with
1% collagenase solution and incubated at 37°C for 15 min. Endothelial
cells were recovered in specific endothelial growing medium (EGM)-2
(Lonza, Cultek, Barcelona, Spain) and incubated at 37°C and 5% CO2.
Exosome isolation and size distribution
Exosome isolation was performed modifying a protocol previously pub-
lished [39]. An extra ultracentrifugation at 40,000 9 g for 30 min. was
performed to remove microvesicles larger than 200 nm–1 lm, thus
avoiding contamination in the final sample. The exosome pellet was
stored at 4°C until further processing in PBS solution. For the
microvesicle protein extraction, the pellet was sonicated – using a
UP200S sonicator (Hielscher Ultrasonics, Teltow, Germany) – 6 cycles
of 6 pulses (amplitude 75%), vortexed for 10 sec., and rotated by wheel
at 4°C overnight. Subsequently, it was sonicated again 6 cycles of 6
pulses (amplitude 75%), vortexed for 10 sec., and stored at 4°C until
further processing. Exosome identity was confirmed by the nanoparticle
tracking system NanoSight NS300 following manufacturer protocols
(Malvern Instruments, Malvern, UK).
Western blot
An equal amount of protein from each sample (35 lg) was loaded. Proto-
cols previously published were used [31]. Membranes were incubated
overnight at 4°C with antibodies against VEGFR-1, VEGFR-2 (1:500;
Abcam, Cambridge, MA, USA), VEGF (1:500; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and b-actin (1:500; Santa Cruz Biotechnology) or
a-tubulin (1:500; Santa Cruz Biotechnology) as loading controls for cells.
Finally, membranes were incubated for 2 hrs at RT in antimouse and anti-
rabbit IgG-HRP (1:10,000; Santa Cruz Biotechnology). Bands were visual-
ized with ECL (Pierce, Thermo Scientific, Rockford, IL, USA) and detected
with Image Quant LAS-4000 mini (GE Healthcare, Uppsala, Sweden). Pro-
tein levels were quantified by densitometry using ImageJ software (NIH,
Bethesda, MD, USA). Protein expression intensity was normalized to the
amount of loaded protein and plotted as a percentage of the control group.
Electron microscopy
Cells were seeded in a Lab-Tek chamber slide with eight wells (Nalge
Nunc International, Naperville, IL, USA) and were fixed in 3% glutaralde-
hyde for 2 hrs at 37°C. Cells were post-fixed in 2% OsO4 for 1 hr at
room temperature and stained in 2% uranyl acetate in the dark for
2 hrs at 4°C. Finally, cells were rinsed in distilled water, dehydrated in
ethanol and infiltrated overnight in Durcupan resin (Fluka, Sigma-
Aldrich, St. Louis, MO, USA). Following polymerization, embedded cul-
tures were detached from the chamber slide and glued to araldite
blocks. Ultrathin sections (0.06–0.08 lm) were prepared with the Ultra-
cut and stained with lead citrate. Finally, grids were covered with hand-
made Formvar and photomicrographs were obtained under a
transmission electron microscope FEI Tecnai G2 Spirit (FEI Europe,
Eindhoven, Netherlands) using a digital camera Morada (Olympus Soft
Image Solutions GmbH, M€unster, Germany).
Exosome pellets were resuspended in PBS and ultracentrifuged at
120,000 9 g for 70 min. at 4°C. After that, approximately 10 lg of the
sample was resuspended in PBS on parafilm. The sample was fixed by
depositing a drop of 2% PFA on the parafilm and placing the grid
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(Mesh with Formvar) on top of the drop. Negative staining was
performed with 2% uranyl acetate. Photomicrographs were obtained
using the transmission electron microscope previously described. Exo-
somes were identified under the microscope solely based on size and
morphology.
Flow cytometry
Exosomes were scrutinized by applying anti-CD9 (Abcam), a well-estab-
lished exosome marker [39–41], using a FACScan flow cytometer
(Beckman Coulter, Alcobendas, Spain). Similarly, antibodies anti-VEGFR-
1 and -2 (Abcam) were used. Five hundred thousand events were col-
lected for each sample. Results were analysed with BD FAC Suite soft-
ware (Fullerton, CA, USA).
Reverse transcription-PCR and real-time
quantitative PCR
Following stress treatment, total RNA was obtained from ARPE-19 cells
and from derived exosomes using RNeasy Micro/Mini Kits (Qiagen, Hil-
den, Germany) according to manufacturer0s instructions. After extrac-
tion, total RNA was reversely transcribed (cDNA synthesis) using GoTaq
PCR master mix (Promega, Fitchburg, WI, USA) under the following
reaction conditions: 65°C for 5 min., 42°C for 60 min. and 70°C for
A
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Fig. 1 Exosome biogenesis. Formation of MVBs was observed in untreated cells (arrow in A) (higher magnification in the inset). Exosomes released
from ARPE-19 cells exhibit the classical morphology and size (50–150 nm). They were detected in extracellular medium from untreated cells (B)
and from 80 mM ethanol-treated cells (C). Flow cytometry exosome detection was performed targeting CD9. Size-distribution analysis of exosomes
was performed by Nanosight (D). Control ARPE-19 cells released a lower number of exosomes (first plot in E) than those cells treated with 40 mM
(second plot in E), and 80 mM (third plot in E). Quantification is shown in the bar graph. Scale bars represent 500 lm in A, 500 nm in the inset,
and 100 nm in B and C. Values are expressed as mean  S.E.M. (N = 3). Significance levels: P < 0.05 (*).
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10 min. The cDNA was then subjected to a real-time quantitative PCR
(qPCR) using SYBR Green Supermix (Applied Biosystems, Carlsbad,
CA, USA) in a Roche 234 LightCycler 480 PCR System. Primer sequences
were: VEGFR-1: Fwd 50-CCA CTT GAC ACT TTG ATC CCT G-3; Rev 50-ATG CCC ATT
GAC TGT TGC TTC-30; VEGFR-2: Fwd 50-AGG GAC TTG GAC TGG CTT
TG-30; Rev 50-AGG CTC CAG TGT CAT TTC CG-30). Each sample was
analysed in triplicates and a cycle threshold (Ct) value of transcripts
was determined in exponential phase using Light Cycler software 4.0.
Finally, X-fold change in mRNA levels was determined by applying
2DDCT method. DCt values were calculated using endogenous control
genes ribosomal S18 (Fwd 50-GTCTGTGATGCCCTTAGATG-30; Rev 50-
AGCTTAT GACCCGCACTTAC-30) and GAPDH (Fwd 50-CAATGACCCCTTCATT-
GACC-30; Rev 50-GATCTCGCTCCTGGAAGATG-30) as referenced [42, 43].
Vasculogenesis assay
Vasculogenesis was analysed in Matrigel (Becton Dickinson, Bedford, MA,
USA) as previously described [44]. After treating the cells in the absence
or presence of RPE-derived exosomes for 24 hrs, HUVEC (6 9 104 cells/
well) were recovered and seeded on Matrigel-coated wells for 5 hrs.
Matrigel was previously diluted with EGM-2 media, FBS free and allowed
to solidify for 30 min. at 37°C. Then, pictures were taken with a Nikon
Eclipse-Ti inverted microscope (Nikon, Tokyo, Japan).
Results
Isolation and characterization of ARPE-19 cell-
derived exosomes
After isolation, exosome identity was confirmed by electron microscopy.
Multivesicular bodies were observed within ARPE-19 cells, before and
after ethanol exposure (Fig. 1A). Exosomes were observed in the extra-
cellular medium of both control cells and ethanol-treated cells (Fig. 1B
and C). Exosomes exhibited the typical characteristic morphology (cup-
shaped) and size (diameter between 50 and 150 nm). Exosome size
was confirmed by the Nanosight tracking system (Fig. 1D).
For exosome counting, we used an anti-CD9 antibody bound to a
fluorescent antibody (APC). Ethanol-treated ARPE-19 cells released a
higher amount of exosomes into the extracellular medium than non-
treated ones (Fig. 1E). In fact, such was observed to occur in a con-
centration-dependent manner, as cells treated with 80 mM ethanol
released a larger number of exosomes compared to those treated
with 40 mM. The difference between control and treated group was
only significant when ethanol concentration was 80 mM.
VEGF and VEGFR-1 from ARPE-19 cells
A number of different cells are known to release VEGF into the extracel-
lular medium, and RPE cells are among them. Control ARPE-19 cells
released baseline levels of VEGF (Fig. 2A, first band). After ethanol treat-
ment, ARPE-19 cells were noted to release a higher amount of VEGF
glycoprotein. A significant fourfold increase in the release of VEGF was
Fig. 2 VEGF and VEGFR-1 from ARPE-19 cells. ARPE-19 cells were
incubated for 24 hrs in the absence (control) or presence of ethanol,
and the result was analysed by Western blot. Non-treated cells secreted
a baseline amount of VEGF into the medium (first band in A), whereas
ethanol-treated cells secreted a significantly higher concentration of
VEGF. Those observations were made using 40 mM ethanol (second
band in A) and 80 mM ethanol (third band in A). Conversely, VEGFR-1
did not show a significant change in release when cells were exposed
to ethanol damage (B). All experiments were normalized to the loading
control (B-actin or a-tubulin). Values are expressed as mean  S.E.M.
(N = 3). Significance levels: P < 0.01 (**).
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observed in cells treated with only 40 mM ethanol (Fig. 2A, second
band). Apparently, VEGF release after oxidative insult by ethanol follows
a concentration-dependent manner, as it was observed that cells treated
with 80 mM ethanol showed a significant sixfold increase in VEGF,
when compared to untreated ARPE-19 cells (Fig. 2A, third band).
It is well established that following a low stress insult, some
cells can release an increased amount of VEGF receptors (VEGFR-
1 and -2). In this study, it was essential to verify whether the
release of VEGF receptors following stress was a direct one or
required the assistance of another mechanism, such as exosome
secretion. Therefore, expression of VEGFR-1 was studied in both
ARPE-19 cells and exosomes secreted by them. When VEGFR-1
expression was tested in ARPE-19 cells, no significant difference
was noted between untreated and treated cells, either with 40 or
80 mM ethanol (Fig. 2B). Expression of VEGFR-2 was below
detectable levels.
VEGFR-1 and VEGFR-2 in ARPE-19 cell-derived
exosomes
Presence of VEGFR-1 and -2 in exosomes was studied by means of
flow cytometry and Western blot. A portion of the exosomes released
from untreated ARPE-19 cells presented VEGFR-1 in their membranes
Fig. 3 Effects of ethanol in exosomal VEGFRs content. ARPE-19 cells were incubated for 24 hrs in the absence (control) or presence of different
ethanol concentrations. Released exosomes were scrutinized by flow cytometry and Western blot. VEGFR-1 protein was detected in control and
ethanol groups, being significantly different at 80 mM of ethanol (A). VEGFR-2 protein was also found in exosomes released from untreated cells,
and its levels significantly rose in an ethanol concentration-dependent manner (at 40 and 80 mM) (B). Presence of VEGFR-1 in exosomes released
by ARPE-19 was also observed by Western blot, and results were in agreement with cytometry experiments (C). Values are expressed as
mean  S.E.M. (N = 3). Significance levels: P < 0.05 (*) and P < 0.01 (**).
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(Fig. 3A, first bar). The number of VEGFR-1-positive exosomes showed
a non-significant increase when cells were treated with 40 mM ethanol
(Fig. 3A, second bar). However, the number of VEGFR-1-positive exo-
somes increased significantly in the medium when cells were treated
with 80 mM ethanol (Fig. 3A, third bar). A similar effect was noted
when the expression of VEGFR-2 was studied in exosomes. In
untreated cells, the population that expressed VEGFR-2 barely reached
700 exosomes per lL (Fig. 3B, first bar); when cells were exposed to
40 mM ethanol, VEGFR-2-positive exosomes doubled their number
(Fig. 3B, second bar). Again, the population of VEGFR-2-positive exo-
somes seems to increase in a concentration-dependent manner, as
cells treated with 80 mM ethanol exhibited more than 3000 positive
exosomes per lL (Fig. 3B, third bar).
To verify previous results, Western blot assays were performed.
VEGFR-1 expression was significantly different in the exosome popu-
lation from ARPE-19 cells formerly treated with 80 mM ethanol for
24 hrs (Fig. 3C), thus confirming the results observed in flow cytom-
etry assays. VEGFR-2 was not detectable by blotting analysis because
of the limited detection level of the technique. VEGF presence within
the exosomes was also examined, but it was under detectable levels
in exosomes from both ethanol-treated and untreated cells.
We evaluated mRNA levels of VEGF receptors in exosomes
derived from ARPE-19 control cells and cells treated with various
concentrations of ethanol. VEGFR-1 and VEGFR-2 mRNA levels were
found to be markedly increased in the exosomes from treated cells,
when compared with the control group. In the case of VEGFR-1,
mRNA levels in the exosomes were increased more than 10-fold
when cells where treated with 80 mM ethanol (Fig. 4A). Furthermore,
VEGFR-2 mRNA levels were increased when cells were treated with
40 mM and 80 mM of ethanol (Fig. 4B). Thus, exosomes from dam-
aged retinal cells contain a higher level of VEGFR-1 and VEGFR-2
mRNA, and this phenomenon occurs in a dose-dependent manner.
Tube formation of endothelial cells treated with
exosomes derived from ethanol-treated ARPE-19
cells
The formation of tubes by endothelial HUVEC cells occurred without
external influence, however components in the culture medium are
able to accelerate or inhibit the process. When HUVEC cells were
seeded in Matrigel and treated with the appropriate medium for 5 hrs,
they migrated, assembling in a precise configuration to create tubes
which at the end of the process will materialize as brand new blood
vessels (Fig. 5A). After 5 hrs in culture, HUVEC cells treated with
healthy RPE exosomes seemed to slow the tube formation process
(Fig. 5B). Surprisingly, damaged RPE exosomes had a completely dif-
ferent influence, when used to treat HUVEC cells. Actually, these exo-
somes appeared to influence HUVEC cells, accelerating tube
formation (Fig. 5C). Those results were quantified by observing the
formation of the nodes and the length of the new tubes formed
(Fig. 5D and E respectively). The amount of VEGFR-1 and VEGFR-2 in
endothelial cells was significantly enhanced when exosomes from
stressed ARPE-19 cells were applied to the medium (Fig. 5F and G).
Relative amounts of VEGFR mRNA in HUVEC cells were also exam-
Fig. 4 Exosomes released from ethanol-exposed ARPE-19 cells are
highly enriched in VEGFR-1 and VEGFR-2 mRNAs. VEGFR-1 and
VEGFR-2 transcript levels in exosomes released by ARPE-19 were also
analysed using reverse transcription assay followed by qPCR. ARPE-19
cells were incubated for 24 hrs in the absence (control) or presence of
different ethanol concentrations. RNA was extracted from the exosome
released from ARPE-19 cells. Presence of mRNA of VEGFR-1 was found
in control and ethanol groups, being its level significantly higher at 40
and 80 mM of ethanol (A). VEGFR-2 mRNA was also detected in exo-
somes derived from untreated cells, and its amount increased in an
ethanol concentration-dependent manner (B). Values are expressed as
mean  S.E.M. (N = 3). *Significance level: P < 0.05.
Fig. 5 Vasculogenesis capacity of exosomes-treated HUVEC cells. Exosome-treated and -untreated HUVEC cells were seeded on Matrigel, showing
specific tube formation after 5 hrs. Non-treated HUVEC cells showed basal tube formation (A). Tube formation appeared less effective when HUVEC
cells were treated with exosomes derived from non-treated ARPE-19 cells (B). When HUVEC cells were treated with exosomes derived from EtOH-
treated (80 mM) ARPE-19 cells, tube building was more efficient (C). Node formation (D) and length of the new blood vessels (E) was quantified.
After 5 hrs, HUVEC cells were pulled and VEGFR-1 and VEGFR-2 protein expression were studied by Western Blot (F and G). Loading control with
B-actin was performed for VEGFR-1 and -2 (F). Amounts of mRNA were measured in HUVEC cells before and after exosome treatment, showing an
enhancement when endothelial cells were treated with stressed exosomes (H). Scale bars: 500 lm. Values are expressed as mean  S.E.M.
(N = 3). Significance levels, when compared to control: P < 0.05 (*); when compared to Exo (control): P < 0.05 (#) and P < 0.01 (##).
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ined (Fig. 5H). Compared to untreated cells, those treated with
stressed exosomes showed an eightfold increase of VEGFR-1 mRNA
and a twofold increase of VEGFR-2 mRNA.
Discussion
Previous data indicate that ARPE-19 cells, a human RPE cell line,
when exposed to low-medium stress conditions, do not degenerate
but rather undergo increased autophagy [31], enhanced VEGF release
[45], and heightened exosome secretion [46]. Moreover, low ethanol
concentrations promote oxidative stress in ARPE-19 cells [31, 37].
Moderate levels of ethanol are also known to induce VEGF expression
in cardiomyocytes [47], tumour cells [48] and RPE cells [45].
Recent studies have shown that a number of cell types, including
RPE cells can influence neighbouring cells by the release of exosomes
[49, 50]. In fact, exosomes from retinal astrocytes seem to reduce ves-
sel leakage in a model of AMD, whereas RPE-originating exosomes do
not stop the new vessels from leaking [35]. Moreover, it has been pro-
posed in another AMD model that exosomes released by ageing RPE
cells are able to increase autophagy in neighbouring cells, and that this
can contribute to drusen formation [51]. In parallel, another group
demonstrated that exosomes derived from mesenchymal stem cells
inhibited neovascularization by down-regulating VEGF expression [52].
ARPE-19 cells were treated with low concentrations of ethanol
(40 and 80 mM). As seen in the results section, ARPE-19 cells con-
sistently released exosomes positive for VEGFR-1 and -2. However,
when those cells were treated with ethanol, they secreted a larger
quantity of exosomes, many of which contained membrane-bound
VEGFR-1 and -2. Interestingly, when RT-PCR and qPCR experiments
were performed, higher amounts of VEGFR-1 and -2 mRNA were
observed within the vesicles.
Therefore, when RPE cells are exposed to low amounts of ethanol,
they release a high quantity of exosomes containing VEGF receptors in
their membrane, and VEGFR-1 and -2 mRNA within the exosome. When
RPE-derived exosomes interact with neighbouring endothelial cells,
there would be an increased potential for membrane fusion and, thereby,
incorporation of VEGF receptors in the new cell membrane [53]. Exo-
somes may also release genetic cargo into the cytosol of the second cell
ensuring the delivery of mRNA to its genetic machinery [54], making
possible an augmentation in the expression of VEGF receptors.
Human umbilical vein endothelial cells in culture tend to build
tubes by themselves [44]. Surprisingly, a significant delay in blood
vessel formation was noticed when healthy RPE exosomes were
added to the medium. Stressing this fact, levels of VEGFR-2 were
reduced in the membrane of HUVEC cells after the treatment
(Fig. 5G). On the contrary, when HUVEC cells were influenced by
damaged RPE exosomes, tube formation occurred more effectively.
Furthermore, HUVEC cells influenced by stressed exosomes showed
higher levels of VEGF receptors, both protein and mRNA (Fig. 5F–H).
These facts strongly indicate that healthy RPE exosomes (under
physiological conditions) inhibit choroidal tube formation, whereas
those released from stressed ARPE-19 cells promote vasculogenesis/
angiogenesis. In fact, it has been observed that exosomes secreted
from hypoxic cells promote angiogenesis [55]. This angiogenic effect
might be because of the extra cargo of proteins and mRNA contained
in the exosomes, as RPE-derived exosomes do not contain detectable
levels of VEGF in any case. In conclusion, exosomes maintain certain
control over tube formation, and it somehow depends on the
homoeostatic state of the releasing cell.
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